Which of the following organizations is responsible for test categorization and CLIA studies Quizlet

Diagnostic testing helps health care providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care. The Clinical Laboratory Improvement Amendments (CLIA) regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing. Laboratories can obtain multiple types of CLIA certificates, based on the kinds of diagnostic tests they conduct.

Three federal agencies are responsible for CLIA: The Food and Drug Administration (FDA), Center for Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC). Each agency has a unique role in assuring quality laboratory testing.

FDA

  • Categorizes tests based on complexity
  • Reviews requests for Waiver by Application
  • Develops rules/guidance for CLIA complexity categorization

CMS

  • Issues laboratory certificates
  • Collects user fees
  • Conducts inspections and enforces regulatory compliance
  • Approves private accreditation organizations for performing inspections, and approves state exemptions
  • Monitors laboratory performance on Proficiency Testing (PT) and approves PT programs
  • Publishes CLIA rules and regulations

CDC

  • Provides analysis, research, and technical assistance
  • Develops technical standards and laboratory practice guidelines, including standards and guidelines for cytology
  • Conducts laboratory quality improvement studies
  • Monitors proficiency testing practices
  • Develops and distributes professional information and educational resources
  • Manages the Clinical Laboratory Improvement Advisory Committee (CLIAC)

Resources

  • Webinar - CLIA Waiver Applications Final Guidance Documents
  • Public Databases
  • 42 CFR 493 - Laboratory Requirements
  • Administrative Procedures for CLIA Categorization - Guidance for Industry and Food and Drug Administration Staff (PDF - 124KB)
  • Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices  - Guidance for Industry and Food and Drug Administration Staff
  • Recommendations for Dual 510(k) and CLIA Waiver by Application Studies - Guidance for Industry and Food and Drug Administration Staff

Which of the following organizations is responsible for test categorization and CLIA studies Quizlet

Spotlight

Proposed Rule

CMS and CDC issued a proposed rule to update CLIA fee, histocompatibility and personnel, and alternative sanctions for Certificate of Waiver laboratories. You can download the proposed rule from the Federal Register at: https://www.federalregister.gov/public-inspection.  Search for “CMS-3326-P.” For additional information please see the Fact Sheet (PDF).

Which of the following organizations is responsible for test categorization and CLIA studies Quizlet

Get Online Payment Info (PDF)

Which of the following organizations is responsible for test categorization and CLIA studies Quizlet

The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). In total, CLIA covers approximately 330,000 laboratory entities. The Division of Clinical Laboratory Improvement & Quality, within the Quality, Safety & Oversight Group, under the Center for Clinical Standards and Quality (CCSQ) has the responsibility for implementing the CLIA Program.

The objective of the CLIA program is to ensure quality laboratory testing. Although all clinical laboratories must be properly certified to receive Medicare or Medicaid payments, CLIA has no direct Medicare or Medicaid program responsibilities.

For the following information, refer to the downloads/links listed below:

  • Frequently Asked Questions (FAQs), CLIA Guidance During the COVID-19 Emergency;
  • Frequently asked Questions (FAQs), Abbott i-STAT;
  • For additional information about a particular laboratory, contact the appropriate State Agency (PDF) or  CLIA
    Operations Branch;
  • Information about what is CMS’ authority regarding Laboratory Developed Tests (LDTs) and how does it differ from FDA’s authority is found in the downloads section in the file called "LDT and CLIA FAQs";
  • CMS Blog - FDA & CMS Form Task Force on LDT Quality Requirements;
  • Information on research testing and CLIA is found in the file called "Research Testing and CLIA";
  • Information about direct access testing (DAT) and the CLIA regulations is included in the Direct Access Testing download;
  • OIG reports relating to CLIA;
  • Guidance for Coordination of CLIA Activities Among CMS Central Office, CMS Regional Offices, State Agencies (including State with Licensure Requirements), Accreditation Organizations and States with CMS Approved State Laboratory Programs is contained in the Partners in Laboratory Oversight download;
  • Micro sample pipetting information for laboratories;
  • Information on alternative (non-traditional) laboratory is contained in the Special Alert download;
  • FDA Safety Tip for laboratories on how workload should be calculated when using currently FDA-approved semi-automated gynecologic cytology screening devices; and
  • CDC educational booklet, "PROVIDER-PERFORMED MICROSCOPY PROCEDURES - A Focus on Quality Practices" (In the Related Links section.); and
  • Frequently asked questions to S&C-16-18-CLIA, Personnel Policies for Individuals Directing or Performing Non-waived Tests, are in the Downloads section file called "S&C-16-18-CLIA FAQs".

COMPLAINT REPORTING

To report a complaint about a laboratory, contact the appropriate State Agency (PDF) that is found on the State Agency & Regional Office CLIA Contacts page located in the left-hand navigation pane in this section.  See the Consumer Complaints FAQ (PDF) on how to file a complaint. Additionally, see the Temporary COVID-19 Testing Sites (PDF) infographic, which advises those receiving laboratory services of things to be aware of to ensure they are receiving quality laboratory testing.

QUESTIONS ABOUT the CLIA PROGRAM

  1. For Questions regarding a CLIA certificate or fees: If you have a question related to CLIA fees or payment, CMS-116 applications, demographic updates, certificate status or upgrades, and/or Laboratory Director changes, please call your local State agency for assistance.  Select the State agency based on the physical location of the laboratory.  The State agency maintains the certificate information for new and existing laboratory providers within their state. For a list of our State agency CLIA contacts (PDF), please visit our website at /Regulations-and-Guidance/Legislation/CLIA/Downloads/CLIASA.pdf (PDF)
  2. All other questions about the CLIA program should be submitted to .

Would you like to receive email updates from CLIA?

Sign up for our CLIA Communications Email List with the link below: https://public.govdelivery.com/accounts/USCMS/subscriber/new?topic_id=USCMS_12461 

Downloads

  • CLIA of 1988 Proficiency Testing Regulations Related to Analytes and Acceptable Performance (CMS-3355-F) (PDF)
  • CLIA SARS-CoV-2 Point Of Care Test Enforcement Discretion (PDF)
  • CLIA University Lab Testing (PDF)
  • Frequently Asked Questions (FAQs), Abbott i-STAT (PDF)
  • LDT and CLIA FAQs (PDF)
  • Research Testing and CLIA (PDF)
  • Direct Access Testing (PDF)
  • OIG Reports Related to CLIA (PDF)
  • Partners in Laboratory Oversight (PDF)
  • Micro Sample Pipetting Information (PDF)
  • Special Alert (PDF)
  • S&C-16-18-CLIA FAQs (PDF)
  • MLN006270 - CLIA Program & Medicare Lab Services (PDF)
  • CLIA Fee, Histocompatibility, Personnel, Alternative Sanction NPRM CMS-3326-P (PDF)

Which organization is responsible for test categorization and CLIA studies?

The Centers for Disease Control and Prevention (CDC) is responsible for the CLIA studies, convening the Clinical Laboratory Improvement Amendments Committee (CLIAC) and providing scientific and technical support/consultation to DHHS/CMS. The Food and Drug Administration (FDA) is responsible for test categorization.

Which of the following organizations is responsible for the standards for laboratory procedures?

The correct answer is A) Clinical and Laboratory standards institute. The Clinical and Laboratory Standard Institute is a non-profit organization that adheres to established laboratory standards when performing molecular-based laboratory testing.

What are the three categories of testing under CLIA quizlet?

CLIA'88 regulations require that three different procedures be performed in the quality-control protocol for automated hematology instruments. The procedures are calibration, control sampling testing, and proficiency testing.

What does CLIA stand for quizlet?

Clinical Laboratory Improvements Amendment of 1988.